[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"brand-gpc-biotech":3,"geo-gpc-biotech":-1,"alternatives-gpc-biotech":23},{"id":4,"slug":5,"name":6,"wikidata_qid":7,"gleif_lei":8,"isin":9,"ultimate_parent_id":9,"hq_country_code":10,"hq_city":11,"founded_year":12,"official_website":9,"manufacturing_countries":9,"logo_url":9,"description":13,"is_eu_headquartered":14,"is_eu_manufactured":15,"eu_score_label":16,"attributes":17,"data_quality":18,"enriched_at":19,"created_at":20,"updated_at":21,"ownership_type":9,"stock_exchange":9,"tax_domicile":9,"ultimate_parent_name":9,"ultimate_parent_country":9,"data_hosting_country":9,"cloud_act_exposure":9,"ai_training_on_user_data":9,"dsa_designation":9,"gdpr_fines_total_eur":9,"gdpr_compliance_status":9,"supply_chain_transparency":9,"sustainable_materials":9,"carbon_neutral":9,"repair_recycling_program":9,"pays_eu_taxes":9,"eu_regulatory_fines":9,"b_corp_certified":9,"ethical_certifications":9,"ownership_disclosed":9,"annual_report_published":9,"supply_chain_audit_published":9,"timeline_events":9,"extended_enriched_at":9,"category_primary_id":9,"category_secondary_id":9,"category_confidence":22},"2ef8c390-1ca2-42fa-b1e8-2250c058ed4f","gpc-biotech","GPC Biotech","Q392611","894500XAO2X0XPVAT274",null,"DE","Martinsried",1997,"GPC Biotech was a German biopharmaceutical company focused on the development of cancer therapeutics, notably including the drug candidate satraplatin. The company was acquired by Apeiron Biologics in 2009 and subsequently ceased independent operations.",true,false,"eu_hq",{},"complete","2026-07-19T14:14:12.931+00:00","2026-07-09T05:55:36.669603+00:00","2026-07-22T16:28:01.49762+00:00",0,[]]